• Je něco špatně v tomto záznamu ?

Destruction of Lysozyme Amyloid Fibrils Induced by Magnetoferritin and Reconstructed Ferritin

J. Gombos, L. Balejcikova, P. Kopcansky, M. Batkova, K. Siposova, J. Kovac, K. Zolochevska, I. Safarik, A. Lokajova, VM. Garamus, D. Dobrota, O. Strbak

. 2022 ; 23 (22) : . [pub] 20221111

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22032681

Neurodegenerative disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), or systemic amyloidosis, are characterized by the specific protein transformation from the native state to stable insoluble deposits, e.g., amyloid plaques. The design of potential therapeutic agents and drugs focuses on the destabilization of the bonds in their beta-rich structures. Surprisingly, ferritin derivatives have recently been proposed to destabilize fibril structures. Using atomic force microscopy (AFM) and fluorescence spectrophotometry, we confirmed the destructive effect of reconstructed ferritin (RF) and magnetoferritin (MF) on lysosome amyloid fibrils (LAF). The presence of iron was shown to be the main factor responsible for the destruction of LAF. Moreover, we found that the interaction of RF and MF with LAF caused a significant increase in the release of potentially harmful ferrous ions. Zeta potential and UV spectroscopic measurements of LAF and ferritin derivative mixtures revealed a considerable difference in RF compared to MF. Our results contribute to a better understanding of the mechanism of fibril destabilization by ferritin-like proteins. From this point of view, ferritin derivatives seem to have a dual effect: therapeutic (fibril destruction) and adverse (oxidative stress initiated by increased Fe2+ release). Thus, ferritins may play a significant role in various future biomedical applications.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22032681
003      
CZ-PrNML
005      
20230131150732.0
007      
ta
008      
230120s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms232213926 $2 doi
035    __
$a (PubMed)36430405
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Gombos, Jan $u Department of Medical Biochemistry, Jessenius Faculty of Medicine, Comenius University, 036 01 Martin, Slovakia
245    10
$a Destruction of Lysozyme Amyloid Fibrils Induced by Magnetoferritin and Reconstructed Ferritin / $c J. Gombos, L. Balejcikova, P. Kopcansky, M. Batkova, K. Siposova, J. Kovac, K. Zolochevska, I. Safarik, A. Lokajova, VM. Garamus, D. Dobrota, O. Strbak
520    9_
$a Neurodegenerative disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), or systemic amyloidosis, are characterized by the specific protein transformation from the native state to stable insoluble deposits, e.g., amyloid plaques. The design of potential therapeutic agents and drugs focuses on the destabilization of the bonds in their beta-rich structures. Surprisingly, ferritin derivatives have recently been proposed to destabilize fibril structures. Using atomic force microscopy (AFM) and fluorescence spectrophotometry, we confirmed the destructive effect of reconstructed ferritin (RF) and magnetoferritin (MF) on lysosome amyloid fibrils (LAF). The presence of iron was shown to be the main factor responsible for the destruction of LAF. Moreover, we found that the interaction of RF and MF with LAF caused a significant increase in the release of potentially harmful ferrous ions. Zeta potential and UV spectroscopic measurements of LAF and ferritin derivative mixtures revealed a considerable difference in RF compared to MF. Our results contribute to a better understanding of the mechanism of fibril destabilization by ferritin-like proteins. From this point of view, ferritin derivatives seem to have a dual effect: therapeutic (fibril destruction) and adverse (oxidative stress initiated by increased Fe2+ release). Thus, ferritins may play a significant role in various future biomedical applications.
650    12
$a amyloid $x metabolismus $7 D000682
650    12
$a muramidasa $x chemie $7 D009113
650    _2
$a ferritiny $7 D005293
650    _2
$a železo $x metabolismus $7 D007501
655    _2
$a časopisecké články $7 D016428
700    1_
$a Balejcikova, Lucia $u Institute of Hydrology, Slovak Academy of Sciences, 841 01 Bratislava, Slovakia $1 https://orcid.org/0000000322843482
700    1_
$a Kopcansky, Peter $u Institute of Experimental Physics, Slovak Academy of Sciences, 040 01 Kosice, Slovakia $1 https://orcid.org/0000000252789504
700    1_
$a Batkova, Marianna $u Institute of Experimental Physics, Slovak Academy of Sciences, 040 01 Kosice, Slovakia $1 https://orcid.org/0000000347358942
700    1_
$a Siposova, Katarina $u Institute of Experimental Physics, Slovak Academy of Sciences, 040 01 Kosice, Slovakia $1 https://orcid.org/0000000327785023
700    1_
$a Kovac, Jozef $u Institute of Experimental Physics, Slovak Academy of Sciences, 040 01 Kosice, Slovakia $1 https://orcid.org/0000000277939564
700    1_
$a Zolochevska, Kristina $u Institute of Experimental Physics, Slovak Academy of Sciences, 040 01 Kosice, Slovakia
700    1_
$a Safarik, Ivo $u Department of Nanobiotechnology, Biology Centre, ISBB, Czech Academy of Sciences, 370 05 Ceske Budejovice, Czech Republic $u Regional Centre of Advanced Technologies and Materials, Czech Advanced Technology and Research Institute, Palacky University, 779 00 Olomouc, Czech Republic
700    1_
$a Lokajova, Alica $u Department of Medical Biochemistry, Jessenius Faculty of Medicine, Comenius University, 036 01 Martin, Slovakia
700    1_
$a Garamus, Vasil M $u Helmholtz-Zentrum Hereon, Max-Planck-Str. 1, 21502 Geesthacht, Germany $1 https://orcid.org/0000000193154188
700    1_
$a Dobrota, Dusan $u Department of Medical Biochemistry, Jessenius Faculty of Medicine, Comenius University, 036 01 Martin, Slovakia
700    1_
$a Strbak, Oliver $u Biomedical Center Martin, Jessenius Faculty of Medicine, Comenius University, 036 01 Martin, Slovakia $1 https://orcid.org/0000000202123392
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 23, č. 22 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36430405 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131150728 $b ABA008
999    __
$a ok $b bmc $g 1891433 $s 1184016
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 23 $c 22 $e 20221111 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Možnosti archivace